Innovation in Infectious Disease Care

The Johns Hopkins biocontainment unit (BCU) is a state-of-the art facility designed to care for adult and pediatric patients affected by high-consequence infectious diseases such as COVID-19, Ebola, smallpox, SARS, viral hemorrhagic fevers and other emerging special pathogens. The unit is a multidisciplinary collaboration of experts from across Johns Hopkins and around the world.

Led by Lisa Maragakis and Brian Garibaldi, the BCU is staffed by self-selected health care workers who train extensively to maintain the BCU’s high-level isolation precautions, including intensive infection control measures like robust personal protective equipment donning and doffing procedures. The unit can provide care for up to four patients in an environment that ensures the safety of patients, their families, health care workers and the community at large. When not active for patient care, the BCU serves as a site for research and training for high-consequence pathogens and clinical care.

On this website:
Team | Research | News |Gallery | Contact

View our annual report (pdf) for the 2022 fiscal year.

Biocontainment Unit Virtual Tour

Our Team

Stories of Care at the BCU

Right Here Right Now | Glenn and Georgene Stephens, Recovering From COVID-19

Hope and Care for Patients with COVID-19 Through Point-of-Care Ultrasound

From Our Blog

Read our posts on the Medicine Matters blog. 

Contact Us

Brian Thomas Garibaldi, M.D.
Medical Director and Associate Professor
Division of Pulmonary and Critical Care
Johns Hopkins Biocontainment and Treatment Unit
Email: [email protected]